Ads
related to: order fluconazole 100mg for salegoodrx.com has been visited by 100K+ users in the past month
"Your pet's prescription needs met at a price you can afford." - Patch
- Free Discount Card
Get a Free Discount Card Today and
Start Saving up to 80% Off Your Rx
- Our Social Impact Mission
At GoodRx, values matter. Visit us
to see how we make a difference.
- How GoodRx® Works
Get Rx Coupons, Save Up to 80%
No Commitment & No Fees
- GoodRx® & Medicare
Beat your Medicare Copay!
Discover More Savings Options Today
- Free Discount Card
ebay.com has been visited by 1M+ users in the past month
starfish.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Fluconazole is an antifungal medication used for a number of fungal infections. [5] This includes candidiasis , blastomycosis , coccidioidomycosis , cryptococcosis , histoplasmosis , dermatophytosis , and tinea versicolor . [ 5 ]
Rank Brand Name(s) Generic Name Sales Q1 2014 Sales ($000) Change from Q4 2013 Company(ies) Disease/Medical Use First Approval Date Patent Expiration Date [6] [7]; 1: Abilify
In 2006, Sanofi-Aventis SA and Bristol-Myers Squibb Co., the producers and patent owners of Plavix, the blood thinner drug, settled a patent lawsuit with Apotex. [23] [24] In the settlement, Apotex agreed not to sell a generic version of Plavix until September 2011, in exchange for an unspecified amount of money. [23]
Under veterinary use, its brand name is Flutelmium which is a paste manufactured by Janssen Pharmaceutica N.V. used by veterinarians for protection against internal parasites and worms in dogs and cats.
Itraconazole is a relatively well-tolerated drug (although not as well tolerated as fluconazole or voriconazole) and the range of adverse effects it produces is similar to the other azole antifungals: [22] elevated alanine aminotransferase levels are found in 4% of people taking itraconazole
Often the owner of the branded drug will introduce a generic version before the patent expires in order to get a head start in the generic market. [103] Restructuring has therefore become routine, driven by the patent expiration of products launched during the industry's "golden era" in the 1990s and companies' failure to develop sufficient new ...